Table 1.
Demographics and baseline characteristics
| Characteristic | All Subjects (N = 30) |
|---|---|
| Sex, n (%) | |
| Female | 21 (70.0%) |
| Male | 9 (30.0%) |
| Age (Years) | |
| Mean ± SD | 57.7 ± 9.87 |
| Race, n (%) | |
| Asian | 1 (3.33%) |
| Caucasian | 29 (96.7%) |
| Weight (kg) | |
| Mean ± SD | 68.4 ± 18.8 |
| ECOG performance status, n (%) | |
| 0 | 3 (10.0%) |
| 1 | 14 (46.7%) |
| 2 | 9 (30.5%) |
| 3 | 3 (10.0%) |
| 4 | 1 (3.33%) |
| Primary tumor type, n (%) | |
| Breast | 14 (46.7%) |
| Lung | 5 (16.7%) |
| Pancreas | 3 (10.0%) |
| Prostate | 2 (6.67%) |
| Colon | 1 (3.33%) |
| Tongue | 1 (3.33%) |
| Thyroid | 1 (3.33%) |
| Liver (primary unknown) | 1 (3.33%) |
| Appendix | 1 (3.33%) |
| Biliary | 1 (3.33%) |
| Prior radiotherapy, n (%) | 11 (36.7%) |
| Prior surgery, n (%) | 19 (63.3%) |
| Number of prior chemotherapy regimens, n (%) | |
| < 2 | 19 (63.3%) |
| ≥ 2 | 11 (36.7%) |